开放标签安慰剂的剂量和使用偏好:在一般人口中进行的一项在线调查
Diana Müßgens1, Katharina Schmidt1, Yvonne Nestoriuc2
1Department of Neurology, Center of Translational Neuro- and Behavioral Sciences, University Medicine Essen, University Duisburg, Essen, Germany.
Journal of psychosomatic research
|June 4, 2025
概括
人们对开放式安慰剂 (OLP) 持开放态度,但对药物的外观和剂量的偏好因症状而异. 了解这些偏好可以帮助优化OLP治疗的有效性.
科学领域:
- 心理学 心理学 心理学
- 药理学 药理学是指药理学的学科.
- 医学研究 医学研究
背景情况:
- 开放式安慰剂 (OLP),在完全披露其惰性性质的情况下使用,在改善各种症状方面表现出有效性.
- 然而, OLP 贡献其有效性的具体方面仍然不清楚.
- 之前的研究表明,公众愿意尝试OLP.
研究的目的:
- 调查公众对OLP特征的偏好和期望,包括剂型,摄入频率和定价.
- 评估这些偏好和期望如何因不同OLP药物的外观和症状类型而有所不同.
主要方法:
- 一项调查对532名受访者进行了调查,他们展示了商业上可用的安慰剂药片的照片.
- 受访者表示他们对OLP的偏好和期望在治疗各种症状 (疼痛,疲劳,认知,情绪,睡眠) 的有效性方面.
主要成果:
- 受访者更喜欢每天一次的OLP摄入量,但预计每天两次更有效.
- 观察到偏爱圆形,白色的药丸,基于药丸形状的各种期望.
- 预期的疗效在情绪和睡眠障碍方面最高.
- 愿意为OLP付费的意愿与预期的疗效正相关,在慢性疼痛,情绪和睡眠障碍方面最高.
结论:
- 个人对OLP外观,摄入频率和目标症状的偏好和期望有很大的不同.
- 根据这些个别因素来个性化OLP治疗可能会提高整体疗效.
相关概念视频
The Placebo Effect
6.4K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
6.4K
Blind Procedures
12.2K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
12.2K
Blinding
3.2K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
3.2K
Drug Dosage Regimen: Overview
3.9K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.9K
Dosage Regimen: Fixed Dose
2.0K
Fixed-dose regimens are a common approach to administer drugs to achieve and maintain desired levels of the drug in the body. In this dosing strategy, a specific amount of medication is given at regular intervals, often multiple times a day, to ensure a consistent drug concentration in the bloodstream.
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
2.0K
Dose-Response Relationship: Potency and Efficacy
5.3K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
5.3K


